MedPath

西安利君精华药业有限责任公司

Ownership
-
Established
2000-09-30
Employees
-
Market Cap
-
Website
https://www.xaljjh.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

23

NMPA:23

Drug Approvals

Mefenamic Acid Dispersible Tablets

Product Name
甲芬那酸分散片
Approval Number
国药准字H20080405
Approval Date
Apr 14, 2023
NMPA

Erythromycin Suppositories

Product Name
红霉素栓
Approval Number
国药准字H61020445
Approval Date
Oct 19, 2020
NMPA

Erythromycin Suppositories

Product Name
红霉素栓
Approval Number
国药准字H61020446
Approval Date
Oct 19, 2020
NMPA

脑心清胶囊

Approval Number
国药准字Z20060292
Approval Date
Sep 9, 2020
NMPA

益肝灵胶囊

Approval Number
国药准字Z20026901
Approval Date
Sep 9, 2020
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H61020448
Approval Date
Sep 9, 2020
NMPA

Azithromycin Dispersible Tablets

Product Name
阿奇霉素分散片
Approval Number
国药准字H20113219
Approval Date
Aug 26, 2020
NMPA

Indometacin Capsules

Product Name
吲哚美辛胶囊
Approval Number
国药准字H61020449
Approval Date
Aug 26, 2020
NMPA

Sodium Chloride

Product Name
氯化钠
Approval Number
国药准字H61020502
Approval Date
Jul 31, 2020
NMPA

Tetracycline Hydrochloride Capsules

Product Name
盐酸四环素胶囊
Approval Number
国药准字H61021971
Approval Date
Jul 31, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.